The Scientist

» antibiotics

Most Recent

image: The Sum of Our Parts

The Sum of Our Parts

By , and | July 1, 2015

Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

4 Comments

image: Antibiotics and the Gut Microbiome

Antibiotics and the Gut Microbiome

By | June 30, 2015

Antibiotics given to infant mice may have long-term effects on the animals’ metabolism and gut microbiota. 

1 Comment

image: Alternate Pathways Yield New Antibiotics

Alternate Pathways Yield New Antibiotics

By | May 29, 2015

Scientists tinker with biosynthetic pathways to make versions of a common antibiotic that stunt drug-resistant bacteria.

0 Comments

image: Widely Used Antibiotics Affect Mitochondria

Widely Used Antibiotics Affect Mitochondria

By | March 12, 2015

From plants to mice and human cells, tetracyclines lead to mitochondrial dysfunction in model organisms.

9 Comments

image: Anticipating Resistance

Anticipating Resistance

By | February 16, 2015

Using computational algorithms and experimental evolution, researchers are predicting antimicrobial-resistance patterns to improve drug design. 

3 Comments

image: B Cell Bosses

B Cell Bosses

By | February 1, 2015

Gut bacteria in mice spur regulatory B cells to differentiate and release an anti-inflammatory cytokine.

0 Comments

image: New Antibiotic from Soil Bacteria

New Antibiotic from Soil Bacteria

By | January 7, 2015

Researchers have isolated a new kind of antibiotic from a previously unknown and uncultured bacterial genus.  

3 Comments

image: Fat to the Rescue

Fat to the Rescue

By | January 5, 2015

Adipocytes under the skin help fight infections by producing an antimicrobial agent.

2 Comments

image: Antibiotic Resistance Among Wildlife

Antibiotic Resistance Among Wildlife

By | December 11, 2014

Even animals that live far from humans are developing resistance to antibiotics.

2 Comments

image: Merck Buys Cubist for $8.4B

Merck Buys Cubist for $8.4B

By | December 11, 2014

Hours after the pharmaceutical giant announced the acquisition, a federal judge invalidated key patents behind the antibiotic maker’s most lucrative product.

0 Comments

Advertisement

Popular Now

  1. Antibiotics and the Gut Microbiome
  2. Sex Differences in Pain Pathway
  3. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
The Scientist